logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
20/12/2025
Deutsche Bank has raised Tesla's target stock price from $470 per share to $500 per share, maintaining a "buy" rating on Tesla.
Latest
2 m ago
Sanofi: Will reduce the prices of certain drugs used in the United States to treat diabetes, cardiovascular and neurological diseases, as well as cancer by an average of 61%.
3 m ago
American President Trump: Tariff threats force pharmaceutical companies to reach agreements.
3 m ago
Amgen: Working with the US government to take action to lower the cost of drugs for American patients. Since 2018, Amgen has invested over $40 billion in manufacturing and research and development. It will expand its "direct-to-patient" program AmgenNow to include Aimovig and Amjevita. All three drugs will also be available through TRUMPRX.GOV. Aimovig and Amjevita will be offered at a discounted price of $299 per month.
3 m ago
Aimovig and Amjevita will be offered at a discounted price of $299 per month. The "Direct-to-Patient" program AmgenNow will be expanded to include Aimovig (erenumab-aooe) and Amjevita (adalimumab-atto). All three drugs will also be available through TRUMPRX.GOV. Working with the U.S. government to take action to lower drug costs for American patients. Amgen has invested over $40 billion in manufacturing and research and development since 2018.
3 m ago
The US Department of the Treasury has extended the license protecting CITGO Petroleum Corporation, a subsidiary of Chevron, from creditors' claims until February 3, 2026.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.